Dacarbazine and haemoglobin decreased Patient Reports February 11, 2012

Dacarbazine Side Effects Report #5132460-5
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2006. Male patient, 66 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: aortic aneurysm rupture, back pain , haemoglobin decreased, hypertension. Dacarbazine dosage: 1730-1710MG/IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5754810-9
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on May 13, 2008. Male patient, 66 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: aortic aneurysm rupture, back pain , haemoglobin decreased, hypertension. Dacarbazine dosage: 1730-1710MG/IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4934204-6
Dacarbazine side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: fall , haematocrit decreased, haemoglobin decreased, intracranial tumour haemorrhage, malignant neoplasm progression, metastatic malignant melanoma, pleural effusion, pyrexia. Dacarbazine dosage: 1900-1880 MG* INTRAVENOUS. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5041776-2
Dacarbazine side effect was reported by a Physician from UNITED STATES on June 21, 2006. Male patient, 57 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: cerebral ischaemia, dehydration, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, pyrexia, red blood cell count decreased, syncope, white blood cell count decreased. Dacarbazine dosage: unknown. During the same period patient was treated with LOTENSIN. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #4760936-9
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 26, 2005. Female patient, 38 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haematuria, haemoglobin decreased, nausea , overdose, pyrexia, thrombocytopenia. Dacarbazine dosage: unknown. During the same period patient was treated with GENASENSE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6059379-X
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 28, 2009. Female patient, 62 years of age, weighting 149.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: asthenia, dehydration, dizziness , haemoglobin decreased, hepatic enzyme increased, loss of consciousness, orthostatic hypotension, presyncope. Dacarbazine dosage: 800MG/M2 EVERY 3 WEEKS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4853003-7
Dacarbazine side effect was reported by a Pharmacist from CANADA on Nov 29, 2005. Male patient, 66 years of age, weighting 186.7 lb, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: blood bilirubin increased, cryptogenic organizing pneumonia, haemoglobin decreased, lipase increased, respiratory distress, respiratory failure. Dacarbazine dosage: 375 MG/M2 IV. During the same period patient was treated with BLEOMYCIN, CEFUROXIME. Patient was hospitalized. Patient died on 10/03/2005.

Dacarbazine Side Effects Report #6140339-5
Dacarbazine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Mar 25, 2009. Male patient, 17 years of age, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, haemoglobin decreased, lymphadenopathy, thymus enlargement. Dacarbazine dosage: 375 MG/M2, 6 CYCLES. During the same period patient was treated with VINBLASTINE SULPHATE, DOXORUBICIN HYDROCHLORIDE. Patient recovered.

Dacarbazine Side Effects Report #4723846-9
Dacarbazine side effect was reported by a Physician from UNITED STATES on July 08, 2005. Female patient, 61 years of age, was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: duodenal neoplasm, gastric neoplasm, haematocrit decreased, haemoglobin decreased, lymphadenopathy, mucosal ulceration, neoplasm progression, red blood cell count decreased, small intestinal haemorrhage. Dacarbazine dosage: 800 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DECITABINE, GLYBURIDE, ATENOLOL, ATORVASTATIN CALCIUM, COLACE. Patient was hospitalized. Patient recovered.